SB

Shankerlal Bhuramal Sharma

Active Director Director DIN 01722130
DIN 01722130 First appointment Jun 2005 Primary industry Chemicals and Materials
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 3 historical roles
Total affiliations 5 Since Jun 2005
Shareholding value •••• Premium profile

About Shankerlal Bhuramal Sharma

Data last updated:

Shankerlal Bhuramal Sharma is a Director at Malvika Herbopharma Private Limited (since 2012) and Director at Cyan Formulators Private Limited (since 2005). The companies operate in Chemicals and Materials and Financial Services. The 2 current companies with reported revenue have a combined latest revenue of ₹34.9 Lakh; the largest is Malvika Herbopharma Private Limited at ₹18.5 Lakh (FY 2025). Earlier, Shankerlal Bhuramal Sharma was a Director at Kesar Petroproducts Limited (2008–2011) and Additional Director at Shreyas Intermediates Limited (2012) and 1 more.

DIN 01722130
Primary Designation Director
Industry Chemicals and Materials
First Appointment 01 Jun 2005
Oldest Company Age 37 yrs
Largest company Malvika Herbopharma Private Limited · ₹18.5 Lakh (FY 2025)
Combined revenue ₹34.9 Lakh across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Malvika Herbopharma Private Limited U24230MH1995PTC086888
Director16 Jul 20121995₹18.5 Lakh (FY 2025)Active
Cyan Formulators Private Limited U65990MH1989PTC050900
Director01 Jun 20051989₹16.3 Lakh (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kesar Petroproducts Limited L23209PN1990PLC054829
Director01 Jan 20081990₹188 Cr (FY 2025)Active
Shreyas Intermediates Limited L24120PN1989PLC145047
Additional Director07 Apr 20121989₹50.5 Lakh (FY 2024)Active
Designated Partner13 Dec 20112011Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Cyan Formulators Private Limited
Kesar Flooring (India) Llp
Malvika Herbopharma Private Limited
Kesar Petroproducts Limited
Premium access

Shareholding and investment profile for Shankerlal Bhuramal Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shankerlal Bhuramal Sharma

Shankerlal Bhuramal Sharma currently holds 2 directorships: Malvika Herbopharma Private Limited (Director, since 16 Jul 2012, revenue ₹18.5 Lakh (FY 2025)); Cyan Formulators Private Limited (Director, since 01 Jun 2005, revenue ₹16.3 Lakh (FY 2025)).

Shankerlal Bhuramal Sharma was first appointed on 01 Jun 2005 as Director at Cyan Formulators Private Limited. The most recent appointment on record is 16 Jul 2012 at Malvika Herbopharma Private Limited.

The 2 current companies of Shankerlal Bhuramal Sharma that report revenue have a combined latest revenue of ₹34.9 Lakh: Malvika Herbopharma Private Limited ₹18.5 Lakh (FY 2025); Cyan Formulators Private Limited ₹16.3 Lakh (FY 2025).

Shankerlal Bhuramal Sharma held 3 earlier board appointments: Kesar Petroproducts Limited (Director, 01 Jan 2008 to 26 May 2011); Shreyas Intermediates Limited (Additional Director, 07 Apr 2012 to 31 Jul 2012); Kesar Flooring (India) Llp (Designated Partner, from 13 Dec 2011).

The current boards of Shankerlal Bhuramal Sharma's companies include Dinesh Shankarlal Sharma (Malvika Herbopharma Private Limited), Shreyas Dinesh Sharma (Malvika Herbopharma Private Limited), Shashikant Shripat Chavan (Cyan Formulators Private Limited), Surya Prakash Sitaram Pandey (Cyan Formulators Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available